Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Total Payout Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600645 Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
70 GF Score
Price ¥19.05
GF Value ¥21.64
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zhongyuan Union Cell & Gene Engineering Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Zhongyuan Union Cell & Gene Engineering's current Total Payout Ratio is .

Zhongyuan Union Cell & Gene Engineering Total Payout Ratio Related Terms

Zhongyuan Union Cell & Gene Engineering Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongyuan Union Cell & Gene Engineering Total Payout Ratio Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:600645 vs VRTX, REGN, MRNA: Total Payout Ratio Comparison

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongyuan Union Cell & Gene Engineering Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio falls into.


SHSE:600645
70GF Score
Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongyuan Union Cell & Gene Engineering Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -0) / 130.44544254
=0.00

Zhongyuan Union Cell & Gene Engineering's Total Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0 + 0 + -0) / 38.60767874
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering stock appears to be undervalued. The current stock price of ¥19.05 is trading 12% below its estimated GF Value™ of ¥21.64. GuruFocus considers Zhongyuan Union Cell & Gene Engineering to be Modestly Undervalued.

Key valuation signals for SHSE:600645:

  • Total Payout Ratio:
  • GF Value™: ¥21.64 vs. price of ¥19.05 (12% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhongyuan Union Cell & Gene Engineering Business Description

Address 45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
70GF Score

Get the complete analysis for SHSE:600645

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.05
Price
¥21.64
GF Value